CA2649090A1 - Intramuscular antiviral treatments - Google Patents

Intramuscular antiviral treatments Download PDF

Info

Publication number
CA2649090A1
CA2649090A1 CA002649090A CA2649090A CA2649090A1 CA 2649090 A1 CA2649090 A1 CA 2649090A1 CA 002649090 A CA002649090 A CA 002649090A CA 2649090 A CA2649090 A CA 2649090A CA 2649090 A1 CA2649090 A1 CA 2649090A1
Authority
CA
Canada
Prior art keywords
compound
formula
pharmaceutically acceptable
acceptable salt
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002649090A
Other languages
English (en)
French (fr)
Inventor
Yarlagadda S. Babu
Pooran Chand
Shanta Bantia
Shane Arnold
John Michael Kilpatrick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocryst Pharmaceuticals Inc
Original Assignee
Biocryst Pharmaceuticals, Inc.
Yarlagadda S. Babu
Pooran Chand
Shanta Bantia
Shane Arnold
John Michael Kilpatrick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocryst Pharmaceuticals, Inc., Yarlagadda S. Babu, Pooran Chand, Shanta Bantia, Shane Arnold, John Michael Kilpatrick filed Critical Biocryst Pharmaceuticals, Inc.
Publication of CA2649090A1 publication Critical patent/CA2649090A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
CA002649090A 2006-04-12 2006-04-12 Intramuscular antiviral treatments Abandoned CA2649090A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/013535 WO2007117241A1 (en) 2006-04-12 2006-04-12 Intramuscular antiviral treatments

Publications (1)

Publication Number Publication Date
CA2649090A1 true CA2649090A1 (en) 2007-10-18

Family

ID=37671157

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002649090A Abandoned CA2649090A1 (en) 2006-04-12 2006-04-12 Intramuscular antiviral treatments

Country Status (8)

Country Link
JP (1) JP2009533428A (ru)
CN (1) CN104784166A (ru)
AU (1) AU2006341592A1 (ru)
BR (1) BRPI0621552A2 (ru)
CA (1) CA2649090A1 (ru)
EA (1) EA200870430A1 (ru)
MX (1) MX2008013140A (ru)
WO (1) WO2007117241A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0518443D0 (en) 2005-09-09 2005-10-19 Evolutec Ltd Method of treating myasthenia gravis
CN101367750B (zh) * 2007-08-14 2012-05-23 中国人民解放军军事医学科学院毒物药物研究所 (1s,2s,3s,4r)-3-[(1s)-1-乙酰氨-2-乙基-丁基]-4-胍基-2-羟基-环戊基-1-羧酸水合物及其医药用途
AU2011204483B2 (en) * 2010-01-08 2016-02-11 Volution Immuno Pharmaceuticals Sa EV576 for use in the treatment of viral infections of the respiratory tract
CN102584637B (zh) * 2011-01-17 2014-07-09 天津药物研究院 帕拉米韦水合物晶体、制备方法、药用组合物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1282316A (zh) * 1997-12-17 2001-01-31 生物晶体药品股份有限公司 用作神经氨酸酶抑制剂的取代环戊烷和环戊烯化合物
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments

Also Published As

Publication number Publication date
EA200870430A1 (ru) 2009-06-30
WO2007117241A1 (en) 2007-10-18
AU2006341592A1 (en) 2007-10-18
BRPI0621552A2 (pt) 2011-12-13
MX2008013140A (es) 2009-02-12
CN104784166A (zh) 2015-07-22
JP2009533428A (ja) 2009-09-17

Similar Documents

Publication Publication Date Title
JP6012076B2 (ja) インフルエンザ治療剤
KR101422744B1 (ko) （１ｓ，２ｓ，３ｓ，４ｒ）－３－［（１ｓ）－１－아세틸아미노－２－에틸－부틸］－４－구아니디노－２－하이드록시－사이클로펜틸―１－카복실산 하이드레이트 및 이의 약제학적 용도
CA2649090A1 (en) Intramuscular antiviral treatments
JP6198741B2 (ja) インフルエンザを処置するための化合物
US20180015063A1 (en) Antiviral treatments
AU2013216632B2 (en) Intravenous antiviral treatments
US20070244193A1 (en) Intramuscular antiviral treatments
JP2009538822A5 (ru)
KR20080113099A (ko) 근육내 항바이러스 치료
AU2016262644B2 (en) Intravenous antiviral treatments
US20230151034A1 (en) Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
CN113116899A (zh) 一种用于治疗流感的药物组合物及含有该药物组合物的制剂

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20130412